DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinical Evidence of Combination Therapy Potential for Varoglutamstat in AD at AAIC 2022
DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Study Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Presents Preclinica...
Source: businessinsider.com